stage II gastric cancer
Showing 1 - 25 of >10,000
Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8, Clinical
Not yet recruiting
- Clinical Stage II Esophageal Adenocarcinoma AJCC v8
- +11 more
- Acupressure Therapy
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jun 12, 2023
Epstein-Barr Virus Positive, Gastric Adenocarcinoma, Mismatch Repair Protein Deficiency Trial in New Brunswick (drug, other,
Recruiting
- Epstein-Barr Virus Positive
- +10 more
- Capecitabine
- +3 more
-
Atlanta, Georgia
- +2 more
Dec 10, 2022
Improving Quality of Life in Stage 0-IIIC Gastric Cancer
Recruiting
- Clinical Stage 0 Gastric Cancer AJCC v8
- +17 more
- Best Practice
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Stage II-III Gastric Cancer Trial in Jinan, Qingdao, Yantai (MRD-guided therapy)
Recruiting
- Stage II-III Gastric Cancer
- MRD-guided therapy
-
Jinan, Shandong, China
- +4 more
Nov 27, 2023
Gastric Cancer Stage II, Gastric Cancer Stage III Trial in Qingdao (Robotic radical gastrectomy)
Recruiting
- Gastric Cancer Stage II
- Gastric Cancer Stage III
- Robotic radical gastrectomy
-
Qingdao, Shandong, ChinaDepartment of Gastrointestinal Surgery, Qingdao University Affil
Sep 12, 2023
Gastric Cancer Trial in Shanghai (Serplulimab, Trastuzuma, Chemotherapy)
Recruiting
- Gastric Cancer
- Serplulimab
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 27, 2023
Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage IIA Gastric Cancer AJCC v8
Not yet recruiting
- Clinical Stage I Gastric Cancer AJCC v8
- +24 more
- Capecitabine
- +6 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Mar 15, 2022
Frequency for Stage II/III Gastric Cancer
Completed
- Gastric Cancer
-
Fuzhou, Fujian, ChinaDepartment of Gastric Surgery
Jul 18, 2022
Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8, Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage
Recruiting
- Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
- +85 more
- Patient Monitoring System
- +2 more
-
Philadelphia, PennsylvaniaThomas Jefferson University Hospital
Sep 7, 2022
Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage II Gastroesophageal Junction
Not yet recruiting
- Clinical Stage I Gastric Cancer AJCC v8
- +9 more
- Atezolizumab
- +12 more
- (no location specified)
Apr 26, 2023
Gastric Cancer, Gastric Tumors, Gastric Adenocarcinoma Trial run by the National Cancer Institute (NCI) (Cellvizio (Registered
Not yet recruiting
- Gastric Cancer
- +2 more
- Cellvizio (Registered trademark)Real-Time In Vivo Cellular Imaging Platform with Confocal Miniprobes
- Olympus GIF 190 endoscope
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Single Patient Classifier Prediction for Stage II and III
Recruiting
- Gastric Cancer
-
Seoul, Korea, Republic ofNovomics. Co., Ltd.
Jul 21, 2022
Remote Telemonitoring of Patient-Generated Physiologic Health
Recruiting
- Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
- +171 more
- Patient Monitoring
- Questionnaire Administration
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 15, 2022
Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IVA Gastric Cancer AJCC v8, Clinical Stage IVB Gastric Cancer AJCC v8
Recruiting
- Clinical Stage IV Gastric Cancer AJCC v8
- +26 more
- Biopsy
- +10 more
-
Duarte, California
- +2 more
Jan 25, 2023
Gastric Cancer Stage II, Gastric Cancer Stage III Trial in Beijing (Toripalimab, oxaliplatin, capecitabine)
Recruiting
- Gastric Cancer Stage II
- Gastric Cancer Stage III
- Toripalimab
- +2 more
-
Beijing, Beijing, China
- +1 more
Mar 9, 2022
Adjuvant Huaier Granule Versus SOX in Gastric Cancer Patients
Not yet recruiting
- Gastric Cancer
- Huaier granule
- +2 more
-
Wuhan, Hubei, ChinaWuhan Union Hospital
Aug 11, 2022
Colorectal Adenocarcinoma, Gastric Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Atlanta (Nanoliposomal
Recruiting
- Colorectal Adenocarcinoma
- +13 more
- Nanoliposomal Irinotecan
- Trifluridine and Tipiracil Hydrochloride
-
Atlanta, Georgia
- +2 more
Jan 6, 2023
Clinical Stage 0 Gastric Cancer AJCC v8, Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage I
Recruiting
- Clinical Stage 0 Gastric Cancer AJCC v8
- +27 more
- Fluorouracil
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jul 5, 2022
Collecting Blood Samples From and Without Cancer to Evaluate
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +61 more
- Questionnaire Administration
- Biospecimen Collection
- (no location specified)
Apr 12, 2022
Advanced Pancreatic Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 Trial in
Recruiting
- Advanced Pancreatic Carcinoma
- +27 more
- Biopsy
- Talazoparib
-
Gainesville, Florida
- +3 more
Jan 3, 2023
Pancreatic Ductal Adenocarcinoma, Colorectal Adenocarcinoma, Gastric Adenocarcinoma Trial in Philadelphia (Adenovirus
Recruiting
- Pancreatic Ductal Adenocarcinoma
- +37 more
- Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Nov 2, 2021
Gastric Cardia Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Stage IB Gastric Cancer AJCC v7 Trial in Phoenix,
Active, not recruiting
- Gastric Cardia Adenocarcinoma
- +7 more
- Carboplatin
- +10 more
-
Phoenix, Arizona
- +1 more
May 12, 2022
Stomach Cancer Trial in Seoul (S-1 (452500ACH), OXALIPLATIN (205803BIJ))
Terminated
- Stomach Cancer
- S-1 (452500ACH)
- OXALIPLATIN (205803BIJ)
-
Seoul, Korea, Republic ofKangbuk Samsung Hospital
Dec 6, 2022
Gastric Cancer Stage III Trial in China (Camrelizumab, Oxaliplatin, Tegafur gimeracil oteracil potassium capsule)
Recruiting
- Gastric Cancer Stage III
- Camrelizumab
- +2 more
-
Hangzhou, Zhejiang, China
- +3 more
Feb 4, 2022
Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Gastric Cardia Trial in
Active, not recruiting
- Adenocarcinoma of the Esophagus
- +5 more
- oxaliplatin
- +6 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jul 25, 2022